Table of Contents

1 Exenatide Market Overview

• 1.1 Product Overview and Scope of Exenatide
• 1.2 Classification of Exenatide by Types
  • 1.2.1 Global Exenatide Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Exenatide Revenue Market Share by Types in 2018
  • 1.2.3 Extended-release injectable suspension
  • 1.2.4 Fast release injectable suspension
• 1.3 Global Exenatide Market by Application
  • 1.3.1 Global Exenatide Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Drug store
• 1.4 Global Exenatide Market by Regions
  • 1.4.1 Global Exenatide Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Exenatide Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Exenatide Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exenatide Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Exenatide Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exenatide Status and Prospect (2014-2024)
• 1.5 Global Market Size of Exenatide (2014-2024)

2 Manufacturers Profiles

• 2.1 AstraZeneca
  • 2.1.1 Business Overview
  • 2.1.2 Exenatide Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 AstraZeneca Exenatide Revenue, Gross Margin and Market Share (2017-2018)

3 Global Exenatide Market Competition, by Players

• 3.1 Global Exenatide Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Exenatide Players Market Share
  • 3.2.2 Top 10 Exenatide Players Market Share
• 3.3 Market Competition Trend

4 Global Exenatide Market Size by Regions

• 4.1 Global Exenatide Revenue and Market Share by Regions
• 4.2 North America Exenatide Revenue and Growth Rate (2014-2019)
• 4.3 Europe Exenatide Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Exenatide Revenue and Growth Rate (2014-2019)
• 4.5 South America Exenatide Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Exenatide Revenue and Growth Rate (2014-2019)

5 North America Exenatide Revenue by Countries

• 5.1 North America Exenatide Revenue by Countries (2014-2019)
• 5.2 USA Exenatide Revenue and Growth Rate (2014-2019)
• 5.3 Canada Exenatide Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Exenatide Revenue and Growth Rate (2014-2019)

6 Europe Exenatide Revenue by Countries

• 6.1 Europe Exenatide Revenue by Countries (2014-2019)
• 6.2 Germany Exenatide Revenue and Growth Rate (2014-2019)
• 6.3 UK Exenatide Revenue and Growth Rate (2014-2019)
• 6.4 France Exenatide Revenue and Growth Rate (2014-2019)
• 6.5 Russia Exenatide Revenue and Growth Rate (2014-2019)
• 6.6 Italy Exenatide Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Exenatide Revenue by Countries

• 7.1 Asia-Pacific Exenatide Revenue by Countries (2014-2019)
• 7.2 China Exenatide Revenue and Growth Rate (2014-2019)
• 7.3 Japan Exenatide Revenue and Growth Rate (2014-2019)
• 7.4 Korea Exenatide Revenue and Growth Rate (2014-2019)
• 7.5 India Exenatide Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Exenatide Revenue and Growth Rate (2014-2019)

8 South America Exenatide Revenue by Countries

• 8.1 South America Exenatide Revenue by Countries (2014-2019)
• 8.2 Brazil Exenatide Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Exenatide Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Exenatide Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Exenatide by Countries

• 9.1 Middle East and Africa Exenatide Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Exenatide Revenue and Growth Rate (2014-2019)
• 9.3 UAE Exenatide Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Exenatide Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Exenatide Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Exenatide Revenue and Growth Rate (2014-2019)

10 Global Exenatide Market Segment by Type

• 10.1 Global Exenatide Revenue and Market Share by Type (2014-2019)
• 10.2 Global Exenatide Market Forecast by Type (2019-2024)
• 10.3 Extended-release injectable suspension Revenue Growth Rate (2014-2024)
• 10.4 Fast release injectable suspension Revenue Growth Rate (2014-2024)

11 Global Exenatide Market Segment by Application

• 11.1 Global Exenatide Revenue Market Share by Application (2014-2019)
• 11.2 Exenatide Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Drug store Revenue Growth (2014-2019)

12 Global Exenatide Market Size Forecast (2019-2024)

• 12.1 Global Exenatide Market Size Forecast (2019-2024)
• 12.2 Global Exenatide Market Forecast by Regions (2019-2024)
• 12.3 North America Exenatide Revenue Market Forecast (2019-2024)
• 12.4 Europe Exenatide Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Exenatide Revenue Market Forecast (2019-2024)
• 12.6 South America Exenatide Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Exenatide Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.

Scope of the Report:
The global Exenatide market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Exenatide.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Exenatide market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Exenatide market by product type and applications/end industries.

Market Segment by Companies, this report covers
AstraZeneca

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Extended-release injectable suspension
Fast release injectable suspension

Market Segment by Applications, can be divided into
Hospital
Drug store